Global Anti-inflammatory Biologics Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-inflammatory Biologics Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-inflammatory Biologics by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-inflammatory Biologics by Country/Region, 2017, 2022 & 2028

2.2 Anti-inflammatory Biologics Segment by Type

2.2.1 Synthetic Type

2.2.2 Biological Type

2.3 Anti-inflammatory Biologics Sales by Type

2.3.1 Global Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-inflammatory Biologics Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-inflammatory Biologics Sale Price by Type (2017-2022)

2.4 Anti-inflammatory Biologics Segment by Application

2.4.1 Arthritis

2.4.2 Respiratory Diseases

2.4.3 Dermatology

2.4.4 Gastroenterology

2.4.5 Others

2.5 Anti-inflammatory Biologics Sales by Application

2.5.1 Global Anti-inflammatory Biologics Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-inflammatory Biologics Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-inflammatory Biologics Sale Price by Application (2017-2022)

3 Global Anti-inflammatory Biologics by Company

3.1 Global Anti-inflammatory Biologics Breakdown Data by Company

3.1.1 Global Anti-inflammatory Biologics Annual Sales by Company (2020-2022)

3.1.2 Global Anti-inflammatory Biologics Sales Market Share by Company (2020-2022)

3.2 Global Anti-inflammatory Biologics Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-inflammatory Biologics Revenue by Company (2020-2022)

3.2.2 Global Anti-inflammatory Biologics Revenue Market Share by Company (2020-2022)

3.3 Global Anti-inflammatory Biologics Sale Price by Company

3.4 Key Manufacturers Anti-inflammatory Biologics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-inflammatory Biologics Product Location Distribution

3.4.2 Players Anti-inflammatory Biologics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-inflammatory Biologics by Geographic Region

4.1 World Historic Anti-inflammatory Biologics Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-inflammatory Biologics Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-inflammatory Biologics Annual Revenue by Geographic Region

4.2 World Historic Anti-inflammatory Biologics Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-inflammatory Biologics Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-inflammatory Biologics Annual Revenue by Country/Region

4.3 Americas Anti-inflammatory Biologics Sales Growth

4.4 APAC Anti-inflammatory Biologics Sales Growth

4.5 Europe Anti-inflammatory Biologics Sales Growth

4.6 Middle East & Africa Anti-inflammatory Biologics Sales Growth

5 Americas

5.1 Americas Anti-inflammatory Biologics Sales by Country

5.1.1 Americas Anti-inflammatory Biologics Sales by Country (2017-2022)

5.1.2 Americas Anti-inflammatory Biologics Revenue by Country (2017-2022)

5.2 Americas Anti-inflammatory Biologics Sales by Type

5.3 Americas Anti-inflammatory Biologics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-inflammatory Biologics Sales by Region

6.1.1 APAC Anti-inflammatory Biologics Sales by Region (2017-2022)

6.1.2 APAC Anti-inflammatory Biologics Revenue by Region (2017-2022)

6.2 APAC Anti-inflammatory Biologics Sales by Type

6.3 APAC Anti-inflammatory Biologics Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-inflammatory Biologics by Country

7.1.1 Europe Anti-inflammatory Biologics Sales by Country (2017-2022)

7.1.2 Europe Anti-inflammatory Biologics Revenue by Country (2017-2022)

7.2 Europe Anti-inflammatory Biologics Sales by Type

7.3 Europe Anti-inflammatory Biologics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-inflammatory Biologics by Country

8.1.1 Middle East & Africa Anti-inflammatory Biologics Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-inflammatory Biologics Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-inflammatory Biologics Sales by Type

8.3 Middle East & Africa Anti-inflammatory Biologics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Biologics

10.3 Manufacturing Process Analysis of Anti-inflammatory Biologics

10.4 Industry Chain Structure of Anti-inflammatory Biologics

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-inflammatory Biologics Distributors

11.3 Anti-inflammatory Biologics Customer

12 World Forecast Review for Anti-inflammatory Biologics by Geographic Region

12.1 Global Anti-inflammatory Biologics Market Size Forecast by Region

12.1.1 Global Anti-inflammatory Biologics Forecast by Region (2023-2028)

12.1.2 Global Anti-inflammatory Biologics Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-inflammatory Biologics Forecast by Type

12.7 Global Anti-inflammatory Biologics Forecast by Application

13 Key Players Analysis

13.1 AbbVie

13.1.1 AbbVie Company Information

13.1.2 AbbVie Anti-inflammatory Biologics Product Offered

13.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 AbbVie Main Business Overview

13.1.5 AbbVie Latest Developments

13.2 Johnson & Johnson

13.2.1 Johnson & Johnson Company Information

13.2.2 Johnson & Johnson Anti-inflammatory Biologics Product Offered

13.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Johnson & Johnson Main Business Overview

13.2.5 Johnson & Johnson Latest Developments

13.3 Amgen Inc

13.3.1 Amgen Inc Company Information

13.3.2 Amgen Inc Anti-inflammatory Biologics Product Offered

13.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Amgen Inc Main Business Overview

13.3.5 Amgen Inc Latest Developments

13.4 AstraZeneca PLC

13.4.1 AstraZeneca PLC Company Information

13.4.2 AstraZeneca PLC Anti-inflammatory Biologics Product Offered

13.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca PLC Main Business Overview

13.4.5 AstraZeneca PLC Latest Developments

13.5 Pfizer, Inc

13.5.1 Pfizer, Inc Company Information

13.5.2 Pfizer, Inc Anti-inflammatory Biologics Product Offered

13.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer, Inc Main Business Overview

13.5.5 Pfizer, Inc Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Anti-inflammatory Biologics Product Offered

13.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Roche

13.7.1 Roche Company Information

13.7.2 Roche Anti-inflammatory Biologics Product Offered

13.7.3 Roche Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Roche Main Business Overview

13.7.5 Roche Latest Developments

13.8 Sun Pharmaceutical Industries Ltd

13.8.1 Sun Pharmaceutical Industries Ltd Company Information

13.8.2 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Offered

13.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sun Pharmaceutical Industries Ltd Main Business Overview

13.8.5 Sun Pharmaceutical Industries Ltd Latest Developments

13.9 Sanofi

13.9.1 Sanofi Company Information

13.9.2 Sanofi Anti-inflammatory Biologics Product Offered

13.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sanofi Main Business Overview

13.9.5 Sanofi Latest Developments

13.10 GlaxoSmithKline

13.10.1 GlaxoSmithKline Company Information

13.10.2 GlaxoSmithKline Anti-inflammatory Biologics Product Offered

13.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 GlaxoSmithKline Main Business Overview

13.10.5 GlaxoSmithKline Latest Developments

14 Research Findings and Conclusion

Table 1. Anti-inflammatory Biologics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-inflammatory Biologics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Synthetic Type

Table 4. Major Players of Biological Type

Table 5. Global Anti-inflammatory Biologics Sales by Type (2017-2022) & (K MT)

Table 6. Global Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

Table 7. Global Anti-inflammatory Biologics Revenue by Type (2017-2022) & ($ million)

Table 8. Global Anti-inflammatory Biologics Revenue Market Share by Type (2017-2022)

Table 9. Global Anti-inflammatory Biologics Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Anti-inflammatory Biologics Sales by Application (2017-2022) & (K MT)

Table 11. Global Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Table 12. Global Anti-inflammatory Biologics Revenue by Application (2017-2022)

Table 13. Global Anti-inflammatory Biologics Revenue Market Share by Application (2017-2022)

Table 14. Global Anti-inflammatory Biologics Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Anti-inflammatory Biologics Sales by Company (2020-2022) & (K MT)

Table 16. Global Anti-inflammatory Biologics Sales Market Share by Company (2020-2022)

Table 17. Global Anti-inflammatory Biologics Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Anti-inflammatory Biologics Revenue Market Share by Company (2020-2022)

Table 19. Global Anti-inflammatory Biologics Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Anti-inflammatory Biologics Producing Area Distribution and Sales Area

Table 21. Players Anti-inflammatory Biologics Products Offered

Table 22. Anti-inflammatory Biologics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Anti-inflammatory Biologics Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Anti-inflammatory Biologics Sales Market Share Geographic Region (2017-2022)

Table 27. Global Anti-inflammatory Biologics Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Anti-inflammatory Biologics Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Anti-inflammatory Biologics Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Anti-inflammatory Biologics Sales Market Share by Country/Region (2017-2022)

Table 31. Global Anti-inflammatory Biologics Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Anti-inflammatory Biologics Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Anti-inflammatory Biologics Sales by Country (2017-2022) & (K MT)

Table 34. Americas Anti-inflammatory Biologics Sales Market Share by Country (2017-2022)

Table 35. Americas Anti-inflammatory Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Anti-inflammatory Biologics Revenue Market Share by Country (2017-2022)

Table 37. Americas Anti-inflammatory Biologics Sales by Type (2017-2022) & (K MT)

Table 38. Americas Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

Table 39. Americas Anti-inflammatory Biologics Sales by Application (2017-2022) & (K MT)

Table 40. Americas Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Table 41. APAC Anti-inflammatory Biologics Sales by Region (2017-2022) & (K MT)

Table 42. APAC Anti-inflammatory Biologics Sales Market Share by Region (2017-2022)

Table 43. APAC Anti-inflammatory Biologics Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Anti-inflammatory Biologics Revenue Market Share by Region (2017-2022)

Table 45. APAC Anti-inflammatory Biologics Sales by Type (2017-2022) & (K MT)

Table 46. APAC Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

Table 47. APAC Anti-inflammatory Biologics Sales by Application (2017-2022) & (K MT)

Table 48. APAC Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Table 49. Europe Anti-inflammatory Biologics Sales by Country (2017-2022) & (K MT)

Table 50. Europe Anti-inflammatory Biologics Sales Market Share by Country (2017-2022)

Table 51. Europe Anti-inflammatory Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Anti-inflammatory Biologics Revenue Market Share by Country (2017-2022)

Table 53. Europe Anti-inflammatory Biologics Sales by Type (2017-2022) & (K MT)

Table 54. Europe Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

Table 55. Europe Anti-inflammatory Biologics Sales by Application (2017-2022) & (K MT)

Table 56. Europe Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Anti-inflammatory Biologics Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Anti-inflammatory Biologics Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Anti-inflammatory Biologics Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-inflammatory Biologics Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Anti-inflammatory Biologics Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Anti-inflammatory Biologics

Table 66. Key Market Challenges & Risks of Anti-inflammatory Biologics

Table 67. Key Industry Trends of Anti-inflammatory Biologics

Table 68. Anti-inflammatory Biologics Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Anti-inflammatory Biologics Distributors List

Table 71. Anti-inflammatory Biologics Customer List

Table 72. Global Anti-inflammatory Biologics Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Anti-inflammatory Biologics Sales Market Forecast by Region

Table 74. Global Anti-inflammatory Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Anti-inflammatory Biologics Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Anti-inflammatory Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Anti-inflammatory Biologics Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Anti-inflammatory Biologics Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Anti-inflammatory Biologics Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Anti-inflammatory Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Anti-inflammatory Biologics Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Anti-inflammatory Biologics Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Anti-inflammatory Biologics Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Anti-inflammatory Biologics Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Anti-inflammatory Biologics Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-inflammatory Biologics Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Anti-inflammatory Biologics Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Anti-inflammatory Biologics Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Anti-inflammatory Biologics Revenue Market Share Forecast by Application (2023-2028)

Table 92. AbbVie Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 93. AbbVie Anti-inflammatory Biologics Product Offered

Table 94. AbbVie Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. AbbVie Main Business

Table 96. AbbVie Latest Developments

Table 97. Johnson & Johnson Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 98. Johnson & Johnson Anti-inflammatory Biologics Product Offered

Table 99. Johnson & Johnson Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 100. Johnson & Johnson Main Business

Table 101. Johnson & Johnson Latest Developments

Table 102. Amgen Inc Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 103. Amgen Inc Anti-inflammatory Biologics Product Offered

Table 104. Amgen Inc Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 105. Amgen Inc Main Business

Table 106. Amgen Inc Latest Developments

Table 107. AstraZeneca PLC Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 108. AstraZeneca PLC Anti-inflammatory Biologics Product Offered

Table 109. AstraZeneca PLC Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 110. AstraZeneca PLC Main Business

Table 111. AstraZeneca PLC Latest Developments

Table 112. Pfizer, Inc Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 113. Pfizer, Inc Anti-inflammatory Biologics Product Offered

Table 114. Pfizer, Inc Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 115. Pfizer, Inc Main Business

Table 116. Pfizer, Inc Latest Developments

Table 117. Novartis Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Anti-inflammatory Biologics Product Offered

Table 119. Novartis Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. Roche Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 123. Roche Anti-inflammatory Biologics Product Offered

Table 124. Roche Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 125. Roche Main Business

Table 126. Roche Latest Developments

Table 127. Sun Pharmaceutical Industries Ltd Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 128. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Product Offered

Table 129. Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 130. Sun Pharmaceutical Industries Ltd Main Business

Table 131. Sun Pharmaceutical Industries Ltd Latest Developments

Table 132. Sanofi Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 133. Sanofi Anti-inflammatory Biologics Product Offered

Table 134. Sanofi Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 135. Sanofi Main Business

Table 136. Sanofi Latest Developments

Table 137. GlaxoSmithKline Basic Information, Anti-inflammatory Biologics Manufacturing Base, Sales Area and Its Competitors

Table 138. GlaxoSmithKline Anti-inflammatory Biologics Product Offered

Table 139. GlaxoSmithKline Anti-inflammatory Biologics Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 140. GlaxoSmithKline Main Business

Table 141. GlaxoSmithKline Latest Developments

List of Figures

Figure 1. Picture of Anti-inflammatory Biologics

Figure 2. Anti-inflammatory Biologics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-inflammatory Biologics Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Anti-inflammatory Biologics Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-inflammatory Biologics Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Synthetic Type

Figure 10. Product Picture of Biological Type

Figure 11. Global Anti-inflammatory Biologics Sales Market Share by Type in 2021

Figure 12. Global Anti-inflammatory Biologics Revenue Market Share by Type (2017-2022)

Figure 13. Anti-inflammatory Biologics Consumed in Arthritis

Figure 14. Global Anti-inflammatory Biologics Market: Arthritis (2017-2022) & (K MT)

Figure 15. Anti-inflammatory Biologics Consumed in Respiratory Diseases

Figure 16. Global Anti-inflammatory Biologics Market: Respiratory Diseases (2017-2022) & (K MT)

Figure 17. Anti-inflammatory Biologics Consumed in Dermatology

Figure 18. Global Anti-inflammatory Biologics Market: Dermatology (2017-2022) & (K MT)

Figure 19. Anti-inflammatory Biologics Consumed in Gastroenterology

Figure 20. Global Anti-inflammatory Biologics Market: Gastroenterology (2017-2022) & (K MT)

Figure 21. Anti-inflammatory Biologics Consumed in Others

Figure 22. Global Anti-inflammatory Biologics Market: Others (2017-2022) & (K MT)

Figure 23. Global Anti-inflammatory Biologics Sales Market Share by Application (2017-2022)

Figure 24. Global Anti-inflammatory Biologics Revenue Market Share by Application in 2021

Figure 25. Anti-inflammatory Biologics Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Anti-inflammatory Biologics Revenue Market Share by Company in 2021

Figure 27. Global Anti-inflammatory Biologics Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Anti-inflammatory Biologics Revenue Market Share by Geographic Region in 2021

Figure 29. Global Anti-inflammatory Biologics Sales Market Share by Region (2017-2022)

Figure 30. Global Anti-inflammatory Biologics Revenue Market Share by Country/Region in 2021

Figure 31. Americas Anti-inflammatory Biologics Sales 2017-2022 (K MT)

Figure 32. Americas Anti-inflammatory Biologics Revenue 2017-2022 ($ Millions)

Figure 33. APAC Anti-inflammatory Biologics Sales 2017-2022 (K MT)

Figure 34. APAC Anti-inflammatory Biologics Revenue 2017-2022 ($ Millions)

Figure 35. Europe Anti-inflammatory Biologics Sales 2017-2022 (K MT)

Figure 36. Europe Anti-inflammatory Biologics Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Anti-inflammatory Biologics Sales 2017-2022 (K MT)

Figure 38. Middle East & Africa Anti-inflammatory Biologics Revenue 2017-2022 ($ Millions)

Figure 39. Americas Anti-inflammatory Biologics Sales Market Share by Country in 2021

Figure 40. Americas Anti-inflammatory Biologics Revenue Market Share by Country in 2021

Figure 41. United States Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Anti-inflammatory Biologics Sales Market Share by Region in 2021

Figure 46. APAC Anti-inflammatory Biologics Revenue Market Share by Regions in 2021

Figure 47. China Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Anti-inflammatory Biologics Sales Market Share by Country in 2021

Figure 54. Europe Anti-inflammatory Biologics Revenue Market Share by Country in 2021

Figure 55. Germany Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Anti-inflammatory Biologics Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Anti-inflammatory Biologics Revenue Market Share by Country in 2021

Figure 62. Egypt Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Anti-inflammatory Biologics Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Anti-inflammatory Biologics in 2021

Figure 68. Manufacturing Process Analysis of Anti-inflammatory Biologics

Figure 69. Industry Chain Structure of Anti-inflammatory Biologics

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles